Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03865680Phase 2Completed
Phase 2, randomised, double-blind trial of MI Varnish in White spot lesion (WSL) (2 arms). Primary endpoints: Oral Hygiene Index-Simplified at 30 weeks, Visio-tactile evaluation of the white spot lesion at 30 weeks and 1 more. Started Apr 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03865680.